However, Mendrinou et al. evaluated the association between both polymorphisms and response to anti-TNF drugs (PASI 75 at 6 months) in 100 Greek patients diagnosed with moderate-to-severe psoriasis [105]. The gene discussed is TNF; the disease is psoriasis.